These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7301014

  • 1. [Influence of parathyroidectomy on the anemia of hemodialysis patients (author's transl)].
    Olmer M, Benas P, Elbet M, Ducros J, Salvadori JM.
    Nephrologie; 1980; 1(1):15-7. PubMed ID: 7301014
    [Abstract] [Full Text] [Related]

  • 2. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
    Podjarny E, Rathaus M, Korzets Z, Blum M, Zevin D, Bernheim J.
    Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
    [Abstract] [Full Text] [Related]

  • 3. Anemia and secondary hyperparathyroidism in chronically hemodialyzed patients.
    Rathaus M, Bernheim J.
    Isr J Med Sci; 1979 May; 15(5):415-7. PubMed ID: 447508
    [Abstract] [Full Text] [Related]

  • 4. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL, Chan TT, Ho YW, Lam SH.
    Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
    [Abstract] [Full Text] [Related]

  • 5. Anemia and secondary hyperparathyroidism.
    Zingraff J, Drüeke T, Marie P, Man NK, Jungers P, Bordier P.
    Arch Intern Med; 1978 Nov; 138(11):1650-2. PubMed ID: 718313
    [Abstract] [Full Text] [Related]

  • 6. Blood requirement and subtotal parathyroidectomy in patients with chronic renal failure treated with hemodialysis.
    Szücs J, Makó J, Mérey J.
    Clin Nephrol; 1983 Mar; 19(3):134-6. PubMed ID: 6839563
    [Abstract] [Full Text] [Related]

  • 7. Effect of parathyroidectomy on anemia in chronic renal failure.
    Barbour GL.
    Arch Intern Med; 1979 Aug; 139(8):889-91. PubMed ID: 464702
    [Abstract] [Full Text] [Related]

  • 8. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
    Esposito MG, Cesare CM, De Santo RM, Cice G, Perna AF, Violetti E, Conzo G, Bilancio G, Celsi S, Annunziata F, Iannelli S, De Santo NG, Cirillo M, Livrea A.
    J Nephrol; 2008 Aug; 21 Suppl 13():S92-6. PubMed ID: 18446739
    [Abstract] [Full Text] [Related]

  • 9. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands.
    Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.
    J Nephrol; 2005 Aug; 18(1):92-5. PubMed ID: 15772929
    [Abstract] [Full Text] [Related]

  • 10. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 Aug; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 11. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF, Lee CH, Lee CT, Huang FJ, Hsu KL.
    J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R, Bloom E, Johnson R.
    Adv Perit Dial; 1993 Jun; 9():177-80. PubMed ID: 8105918
    [Abstract] [Full Text] [Related]

  • 15. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Jun; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S, Safárová R, Horácková M, Herink J, Rychlík I, Bahbouh R, Půtová I.
    Cas Lek Cesk; 2001 Apr 12; 140(7):209-13. PubMed ID: 11374225
    [Abstract] [Full Text] [Related]

  • 17. Total parathyroidectomy and autotransplantation.
    Diaz-Buxo JA, Geissinger WT, Walker PJ, Chandler JT, Farmer CD, Holt KL, Wolfe P.
    Clin Nephrol; 1981 Dec 12; 16(6):276-82. PubMed ID: 7318261
    [Abstract] [Full Text] [Related]

  • 18. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul 12; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

  • 19. Parathyroidectomy and improving anemia.
    Jemcov TK, Petakov M, Bogdanovic A, Djukanovic L, Lezaic VD.
    Arch Surg; 2008 Jan 12; 143(1):97-8. PubMed ID: 18209161
    [No Abstract] [Full Text] [Related]

  • 20. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Jan 12; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.